Acute Respiratory Failure Clinical Trial
Official title:
Physiological Effects of the Application of Secretion Removal Device in Invasively Ventilated Patients
In this study the investigators will assess the effects of secretion removal on "noninvasive" respiratory mechanics, in deeply sedated mechanically ventilated patients All the mechanically ventilated patients will be submitted to the recording of compliance and resistance at baseline (time0), immediately after the application of 10 cycles alternating 30 cmH20 during expiration and -30 cmH20 during exhalation (time1). Afterward the patients will undergo an additional trail using the so called "percussion" technique, to assess any synergic effect of this procedure (time2)
In this observational study, the investigators will assess the effects of two secretion
removal techniques on passive respiratory mechanics, in patients undergoing invasive
mechanical ventilation.
Consecutive patients will undergo 3 sequential assessments at time0 (baseline), at time1
after the application of of 10 cycles alternating 30 cmH20 during expiration and -30 cmH20
during exhalation and finally after a 20 sec application of a "percussion technique".
Protocol:
The patients will be ventilated without PEEP and sedated with a benzodiazepine infusion to
produce complete relaxation and adaptation to the ventilator, as assessed by the complete
absence of spontaneous efforts, so that there was no change in inspiratory flow rate, tidal
volume, or respiratory rate during the three measurement periods.
Airway pressure (Paw) and flow (V) will be measured continuously throughout the respiratory
cycle with the transducer and expiratory tidal volume will obtained by electrical integration
of the flow signal.
Arterial blood gas specimens will be withdrawn from the radial artery and analyzed with a
blood gas analyzer The patients will be studied in the semi recumbent position. After
baseline measurements of respiratory mechanics will recorded under control conditions.
Direct measurement of PEEPi will be obtained using the following method:
After several breaths under controlled mechanical ventilation, and with the patient relaxed,
the airway opening is occluded at the end of a tidal expiration, using the end-expiratory
hold button incorporated in the ventilator.
The occlusion will be then released for the mechanical lung inflation, and after a few
breaths the airway opening will be again occluded at the end of the inflation, using the
end-inspiratory hold button of the ventilator.
The static compliance of the total respiratory system (Cst rs) will be corrected for the
compliance of the ventilator tubing and the gas compression (0.8 ml/cm H20 2).
The end-inspiratory occlusion technique also allows determination of the inspiratory
resistive properties of the respiratory system, named R,rs min and R,rsmax, that means the
minimal respiratory resistances (those due mainly to the airways) and maximal respiratory
resistances (those mainly due to stress relaxation and Pendelluft)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05144633 -
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
|
||
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Recruiting |
NCT03021902 -
Nutrition and Exercise in Critical Illness
|
Phase 2 | |
Completed |
NCT02902146 -
Bougie Use in Emergency Airway Management
|
N/A | |
Completed |
NCT02901158 -
Esophageal Manometry in Mechanically Ventilated Patients
|
||
Completed |
NCT02236559 -
High Flow Therapy for the Treatment of Respiratory Failure in the ED
|
N/A | |
Recruiting |
NCT02056093 -
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
|
N/A | |
Terminated |
NCT01083277 -
Variable Ventilation During Acute Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01462279 -
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
N/A | |
Completed |
NCT01114022 -
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
|
N/A | |
Active, not recruiting |
NCT01058421 -
Treatment of Critical Illness Polyneuromyopathy
|
Phase 2 | |
Completed |
NCT00252616 -
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
|
Phase 2/Phase 3 | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Recruiting |
NCT06051292 -
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
|
N/A | |
Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
Recruiting |
NCT05423301 -
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
|
N/A | |
Completed |
NCT02447692 -
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
|
N/A | |
Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
Completed |
NCT04507425 -
High Flow Nasal Cannula With Noninvasive Ventilation
|
N/A |